HIP
VRTX icon

HUB Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

HUB Investment Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
2,140
+311
+17% +$138K 0.02% 436
2026
Q1 		$817K Buy
1,829
+423
+30% +$197K 0.02% 410
2025
Q4 		$637K Buy
1,406
+361
+35% +$156K 0.02% 420
2025
Q3 		$409K Buy
+1,045
New +$437K 0.01% 463

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HUB Investment Partners's VRTX Position: Q2 2026 in Review

HUB Investment Partners increased its Vertex Pharmaceuticals (VRTX) stake by 17% in Q2 2026, buying an estimated $138K and bringing the position to 2,140 shares worth $1.06M. The position accounts for 0.02% of the portfolio, ranked #436.

HUB Investment Partners first reported a position in VRTX in Q3 2025 and has held it in 4 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • HUB Investment Partners held 2,140 shares of Vertex Pharmaceuticals worth $1.06M as of Q2 2026.
  • HUB Investment Partners bought 311 Vertex Pharmaceuticals shares in Q2 2026, an estimated $138K.
  • Vertex Pharmaceuticals made up 0.02% of HUB Investment Partners's portfolio in Q2 2026, its #436 holding.
  • HUB Investment Partners first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.